PWD

Flow Cytometric Test System For Hematopoietic Neoplasms

产品代码
PWD
器械名称
Flow Cytometric Test System For Hematopoietic Neoplasms
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 864.7010
FDA 专业组
Hematology
上市路径
需提交 510(k) 上市前通告
标记
可走第三方审查
FDA 历史累计 510(k)
2 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

Reagents intended for in vitro diagnostic use as a panel for qualitative identification of cell populations by multiparameter immunophenotyping on a flow cytometer. These reagents are used as an aid in the differential diagnosis of hematologically abnormal patients having, or suspected of having the following hematopoietic neoplasms: chronic leukemia, acute leukemia, non-Hodgkin's lymphoma, myeloma, myelodysplastic syndrome (MDS), and/or myeloproliferative neoplasms (MPN)

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

FDA 官方分类页: PWD
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。